SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For March 10, 2003
Commission File Number: 001-11960
AstraZeneca PLC
15 Stanhope Gate, London W1K 1LN, England
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
| Form
20-F X |
Form
40-F __ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934 .
| Yes__ |
No
X |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AstraZeneca
PLC |
|
| Date: March 10, 2003 | By: /s/ G H R Musker Name: G H R Musker Title: Company Secretary & Solicitor |
AstraZeneca PLC
INDEX TO EXHIBITS
| 1. | AstraZeneca Annual Review 2002 |
| 2. | AstraZeneca Annual Report and Form 20-F 2002 |